SCHEMBL23827382

SCHEMBL23827382

CC(C)(C)OC(=O)NCCCn1cc(NC(=O)c2ccc(OCC(ON3C(=O)c4ccccc4C3=O)C(=O)O)cc2)cn1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCD O00767 1/20 0.43
▸ MAPT P10636 3/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ PLA2G1B P04054 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CYP2D6 P10635 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ ATG4B Q9Y4P1 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.37
▸ NPSR1 Q6W5P4 2/20 0.37
▸ NAMPT P43490 2/20 0.37
▸ BRD4 O60885 2/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TAS2R8 Q9NYW2 2/20 0.36
▸ HDAC1 Q13547 1/20 0.36
▸ SUCNR1 Q9BXA5 4/20 0.35
▸ MALT1 Q9UDY8 1/20 0.35
▸ PDPK1 O15530 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23827380 1.00 SCD (0.43) SCDMAPTSMN1; SMN2PLA2G1BCYP1A2
SCHEMBL23827383 0.93 SCD (0.39) SCDMAPTTDP1NPSR1BRD4
SCHEMBL23827381 0.93 SCD (0.39) SCDMAPTTDP1NPSR1BRD4
SCHEMBL23838040 0.88 SCD (0.40) SCDMAPTSMN1; SMN2PLA2G1BCYP1A2
SCHEMBL18991797 0.88 MMP2 (0.39) HDAC1SUCNR1MALT1PDPK1CCNB2
SCHEMBL20566016 0.88 MMP2 (0.39) HDAC1SUCNR1MALT1PDPK1CCNB2
SCHEMBL22013868 0.88 MAPT (0.40) SCDMAPTTDP1NPSR1BRD4
SCHEMBL23838041 0.86 SCD (0.39) SCDMAPTSMN1; SMN2PLA2G1BCYP1A2
SCHEMBL20566482 0.83 FEN1 (0.40) SCDTDP1HDAC1MALT1PDPK1
SCHEMBL20567229 0.83 PDCD1 (0.37) SCDSMN1; SMN2TDP1ALDH1A1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111171014-B Monocyclolactam compounds and uses thereof 南京圣和药业股份有限公司 2023-11-07 — — CN disclosed
CN-112771040-B Monocyclic lactam compounds and uses thereof 南京圣和药业股份有限公司 2022-10-18 — — CN disclosed
US-20220002288-A1 MONOBACTAM COMPOUNDS AND USE THEREFOR NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) 2022-01-06 — — US disclosed
EP-3882246-A1 MONOBACTAM COMPOUNDS AND USE THEREFOR Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) 2021-09-22 — — EP disclosed
CN-112771040-A Monocyclic lactam compounds and uses thereof 南京圣和药业股份有限公司 2021-05-07 — — CN disclosed
CN-111171014-A Monocyclic lactam compounds and uses thereof 南京圣和药业股份有限公司 2020-05-19 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002288-A1 MONOBACTAM COMPOUNDS AND USE THEREFOR BPGM, IL1B, WEE1 SCD 511/4885MAPT 1841/4885SMN1; SMN2 4746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback